JP Morgan Chase
NVLN

JP Morgan Chase’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

JP Morgan Chase’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-600
Closed – – 6115
2019
Q3 		$0 Hold
600
– – ﹤0.01% 6119
2019
Q2 		$0 Sell
600
-1,364
-69% -$1.52K ﹤0.01% 6168
2019
Q1 		$3K Buy
1,964
+1,364
+227% +$1.55K ﹤0.01% 5666
2018
Q4 		$1K Hold
600
– – ﹤0.01% 5650
2018
Q3 		$2K Hold
600
– – ﹤0.01% 5629
2018
Q2 		$2K Sell
600
-3,045
-84% -$12.2K ﹤0.01% 5476
2018
Q1 		$13K Sell
3,645
-228
-6% -$967 ﹤0.01% 5144
2017
Q4 		$12K Sell
3,873
-3,867
-50% -$18.6K ﹤0.01% 5243
2017
Q3 		$54K Buy
7,740
+6,336
+451% +$50.8K ﹤0.01% 4455
2017
Q2 		$13K Sell
1,404
-8,888
-86% -$85.6K ﹤0.01% 4621
2017
Q1 		$110K Buy
10,292
+6,440
+167% +$65.8K ﹤0.01% 4295
2016
Q4 		$32K Buy
+3,852
New +$34.1K ﹤0.01% 4619

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
DMK
David M. Knott $264M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return